Cargando…
Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347612/ http://dx.doi.org/10.1186/1940-0640-10-S1-A9 |
| _version_ | 1782359848327839744 |
|---|---|
| author | Crèvecoeur-MacPhail, Desirée A |
| author_facet | Crèvecoeur-MacPhail, Desirée A |
| author_sort | Crèvecoeur-MacPhail, Desirée A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4347612 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43476122015-03-19 Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users Crèvecoeur-MacPhail, Desirée A Addict Sci Clin Pract Meeting Abstract BioMed Central 2015 2015-02-20 /pmc/articles/PMC4347612/ http://dx.doi.org/10.1186/1940-0640-10-S1-A9 Text en Copyright © 2015 Crèvecoeur-MacPhail; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract Crèvecoeur-MacPhail, Desirée A Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title | Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title_full | Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title_fullStr | Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title_full_unstemmed | Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title_short | Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users |
| title_sort | whose mu fared better? the effect of extended-release naltrexone (xr-ntx) on treatment outcomes for opioid and alcohol users |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347612/ http://dx.doi.org/10.1186/1940-0640-10-S1-A9 |
| work_keys_str_mv | AT crevecoeurmacphaildesireea whosemufaredbettertheeffectofextendedreleasenaltrexonexrntxontreatmentoutcomesforopioidandalcoholusers |